Pharmacists in Richmond, Virginia
613 Pharmacists found in Richmond
Regina Sorbello, RPH
Pharmacist - Pharmacotherapy
4715 Walmsley Blvd, Richmond, VA 23234
804-275-9235 804-275-4642
Dr. Rene Krogsund, PHARMD
Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
1201 Broad Rock Blvd, Richmond, VA 23249
804-675-5000
Richard Keith Kittinger, RPH
Pharmacist
2002 Staples Mill Rd, Richmond, VA 23230
804-285-7823 804-285-7857
Dr. Robert Woodrow Schmidt, PHARM.D.
Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
1201 Broad Rock Blvd, Richmond, VA 23249
804-675-5000
Dr. Robert Anthony Harris, PHARMD, MBA
Pharmacist
1201 Broad Rock Blvd, Richmond, VA 23249
804-675-5976 804-675-5762
Mr. Robert Reaves Griffin Iii, RPH
Pharmacist
3601 Mechanicsville Turnpike, Richmond, VA 23223
804-329-3363 804-329-7471
Robin Smith Earley, RPH
Pharmacist
6900 Atmore Dr, Pharmacy; Room 3127a, Richmond, VA 23225
804-674-3681 804-674-3684
Dr. Robin Michelle Sayles, PHARM D
Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
9609 Jefferson Davis Hwy, Richmond, VA 23237
804-275-1116
Rodney Jones Jr., PHARM.D
Pharmacist
5001 Nine Mile Rd, Richmond, VA 23223
804-253-0687 804-253-1505
Dr. Roger Dale St.clair Jr., PHARM.D.
Pharmacist
2015 Staples Mill Rd, Richmond, VA 23230
804-354-7000
Dr. Ronald Alfred Gregory, PHARMD
Pharmacist
1300 Mactavish Ave, Suite A, Richmond, VA 23230
804-977-5981 804-977-5981
Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.